Research Advances of Secretory Proteins in Malignant Tumors

Overview

Journal Chin J Cancer Res

Specialty Oncology

Date 2021 Mar 12

PMID 33707934

Citations 4

Authors

Na Zhang

Jiajie Hao

Yan Cai

Mingrong Wang

Affiliations

Soon will be listed here.

Abstract

Secretory proteins in tumor tissues are important components of the tumor microenvironment. Secretory proteins act on tumor cells or stromal cells or mediate interactions between tumor cells and stromal cells, thereby affecting tumor progression and clinical treatment efficacy. In this paper, recent research advances in secretory proteins in malignant tumors are reviewed.

Citing Articles

Cancer cells impact the microrheology of endothelial cells during physical contact or through paracrine signalling.

Kefala G, Tsvirkun D, Laurent V, Verdier C Sci Rep. 2025; 15(1):8064.

PMID: 40055419 PMC: 11889160. DOI: 10.1038/s41598-025-92422-w.

Identifying Key Genes as Progression Indicators of Prostate Cancer with Castration Resistance Based on Dynamic Network Biomarker Algorithm and Weighted Gene Correlation Network Analysis.

Liu S, Hu Y, Liu F, Jiang Y, Wang H, Wu X Biomedicines. 2024; 12(9).

PMID: 39335669 PMC: 11429123. DOI: 10.3390/biomedicines12092157.

The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins.

Felekkis K, Papaneophytou C Int J Mol Sci. 2024; 25(6).

PMID: 38542382 PMC: 10969827. DOI: 10.3390/ijms25063403.

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells.

Agnello L, dArgenio A, Caliendo A, Nilo R, Zannetti A, Fedele M Cells. 2023; 12(13).

PMID: 37443843 PMC: 10340747. DOI: 10.3390/cells12131809.

Characterizing viscoelastic properties of human melanoma tissue using Prony series.

Park S, Chien A, Brown I, Chen J Front Bioeng Biotechnol. 2023; 11:1162880.

PMID: 37091343 PMC: 10117758. DOI: 10.3389/fbioe.2023.1162880.

References

Lv C, Dai H, Sun M, Zhao H, Wu K, Zhu J . Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β. Melanoma Res. 2017; 27(2):74-84. DOI: 10.1097/CMR.0000000000000325. View

Fu Y, Zhang Y, Lei Z, Liu T, Cai T, Wang A . Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer. J Hematol Oncol. 2020; 13(1):169. PMC: 7720454. DOI: 10.1186/s13045-020-01009-7. View

Guo J, Chiu C, Wang M, Li F, Chen J . Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44. J Biomed Sci. 2020; 27(1):2. PMC: 6939340. DOI: 10.1186/s12929-019-0600-3. View

Li D, Ji H, Niu X, Yin L, Wang Y, Gu Y . Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer. Cancer Sci. 2019; 111(1):47-58. PMC: 6942430. DOI: 10.1111/cas.14230. View

Liu Z, Xu J, He J, Zheng Y, Li H, Lu Y . A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. Blood. 2014; 124(13):2061-71. PMC: 4186536. DOI: 10.1182/blood-2014-03-557298. View

Qian D, Lu Z, Xu Q, Wu P, Tian L, Zhao L . Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis. Cancer Lett. 2017; 397:43-51. DOI: 10.1016/j.canlet.2017.03.024. View

Berraondo P, Sanmamed M, Ochoa M, Etxeberria I, Aznar M, Perez-Gracia J . Cytokines in clinical cancer immunotherapy. Br J Cancer. 2018; 120(1):6-15. PMC: 6325155. DOI: 10.1038/s41416-018-0328-y. View

Zhang J, Chen J, Wo D, Yan H, Liu P, Ma E . LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung. Clin Cancer Res. 2019; 25(15):4832-4845. DOI: 10.1158/1078-0432.CCR-18-3557. View

Gong B, Kiyotani K, Sakata S, Nagano S, Kumehara S, Baba S . Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer. J Exp Med. 2019; 216(4):982-1000. PMC: 6446862. DOI: 10.1084/jem.20180870. View

10.

Yang X, Zhang X, Fu M, Weichselbaum R, Gajewski T, Guo Y . Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses. Cancer Cell. 2014; 25(1):37-48. PMC: 3927846. DOI: 10.1016/j.ccr.2013.12.004. View

11.

Kim J, Bamlet W, Oberg A, Chaffee K, Donahue G, Cao X . Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers. Sci Transl Med. 2017; 9(398). PMC: 5727893. DOI: 10.1126/scitranslmed.aah5583. View

12.

Song W, Liu W, Zhao H, Li S, Guan X, Ying J . Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway. Nat Commun. 2015; 6:8022. PMC: 4560765. DOI: 10.1038/ncomms9022. View

13.

Wang Y, Yan W, Lu X, Qian C, Zhang J, Li P . Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells. Eur J Cell Biol. 2011; 90(8):642-8. DOI: 10.1016/j.ejcb.2011.03.005. View

14.

Tang H, Leung L, Saturno G, Viros A, Smith D, Di Leva G . Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface. Nat Commun. 2017; 8:14909. PMC: 5399287. DOI: 10.1038/ncomms14909. View

15.

Tang Y, Chen Y, Bao Y, Mahara S, Yatim S, Oguz G . Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer. Proc Natl Acad Sci U S A. 2018; 115(26):E5990-E5999. PMC: 6042102. DOI: 10.1073/pnas.1801348115. View

16.

Chiou J, Chang Y, Tsai H, Lin Y, Huang M, Yang C . Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin. Cancer Res. 2019; 79(24):6113-6125. DOI: 10.1158/0008-5472.CAN-19-0842. View

17.

Dokmanovic M, Shen Y, Bonacci T, Hirsch D, Wu W . Trastuzumab regulates IGFBP-2 and IGFBP-3 to mediate growth inhibition: implications for the development of predictive biomarkers for trastuzumab resistance. Mol Cancer Ther. 2011; 10(6):917-28. DOI: 10.1158/1535-7163.MCT-10-0980. View

18.

Lee K, Nam K, Oh S, Lim J, Kim Y, Lee J . Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling. Breast Cancer Res. 2014; 16(6):479. PMC: 4308848. DOI: 10.1186/s13058-014-0479-6. View

19.

Wang C, Zhang S, Liu J, Tian Y, Ma B, Xu S . Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway. Cell Rep. 2020; 30(6):1780-1797.e6. DOI: 10.1016/j.celrep.2020.01.037. View

20.

Mimeault M, Johansson S, Batra S . Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1. Br J Cancer. 2013; 108(5):1079-91. PMC: 3619053. DOI: 10.1038/bjc.2012.484. View